Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beam Therapeutics, Inc.

25.10
+2.6511.80%
Pre-market: 25.270.1700+0.68%05:20 EDT
Volume:3.83M
Turnover:93.65M
Market Cap:2.54B
PE:-5.43
High:25.13
Open:23.22
Low:23.00
Close:22.45
52wk High:35.25
52wk Low:13.53
Shares:101.16M
Float Shares:89.94M
Volume Ratio:1.31
T/O Rate:4.25%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6207
EPS(LYR):-4.5769
ROE:-41.94%
ROA:-21.02%
PB:2.43
PE(LYR):-5.48

Loading ...

Cathie Wood’s ARK Investment buys 491K shares of Beam Therapeutics today

TIPRANKS
·
Yesterday

Beam Therapeutics Price Target Maintained With a $80.00/Share by HC Wainwright & Co.

Dow Jones
·
Sep 15

Beam Therapeutics Inc. to Participate in Citi's Biopharma Back to School Conference

Reuters
·
Aug 25

BUZZ-U.S. STOCKS ON THE MOVE-Oracle, Kratos, Masimo

Reuters
·
Aug 14

Beam Therapeutics Shares up 1.5% Premarket After U.S. FDA's Tag for Sickle Cell Disease Therapy

THOMSON REUTERS
·
Aug 14

Beam Therapeutics Secures FDA Regenerative Medicine Advanced Therapy Designation for BEAM-101 in Sickle Cell Disease Treatment

Reuters
·
Aug 14

Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (Rmat) Designation Granted to Beam-101 for the Treatment of Sickle Cell Disease

THOMSON REUTERS
·
Aug 14

Beam Therapeutics Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Aug 06

Stock Track | Beam Therapeutics Plummets 5% as Barclays Slashes Price Target

Stock Track
·
Aug 06

Stock Track | Beam Therapeutics Plummets 5% as Barclays Slashes Price Target

Stock Track
·
Aug 06

Beam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 05

Beam Therapeutics Q2 EPS $(1.00) Beats $(1.12) Estimate, Sales $8.47M Miss $13.56M Estimate

Benzinga
·
Aug 05

Beam Therapeutics Q2 net loss widens more than expected

Reuters
·
Aug 05

Earnings Flash (BEAM) Beam Therapeutics Posts Q2 $1 Loss, vs. FactSet Est of $1.11 Loss

MT Newswires Live
·
Aug 05

Beam Therapeutics Inc - Ends Q2 2025 With $1.2 Bln Cash; Runway Into 2028

THOMSON REUTERS
·
Aug 05

FMR LLC Reports Disposal of Common Shares of Beam Therapeutics Inc

Reuters
·
Aug 01

AI Biotech Stocks Shined. Recursion Soared 10%; Absci Up 7%; Crispr Up 6%; Beam And Ginkgo Up 3%

Tiger Newspress
·
Jul 21

Chief Medical Officer Simon Amy Reports Disposal of Common Shares of Beam Therapeutics Inc

Reuters
·
Jul 04

BRIEF-Beam Therapeutics Buys Early-Stage Life Sciences Company

Reuters
·
Jul 04

Beam Therapeutics Inc. Issues 403,128 Shares as Upfront Payment and Announces Potential Additional Milestone Shares Worth Up to $89 Million in Acquisition Deal

Reuters
·
Jul 04